SeaSpine to Participate in the Ladenburg Thalmann 2021 Virtual Healthcare Conference

Rhea-AI Summary

SeaSpine Holdings Corporation (NASDAQ: SPNE) will present at the Ladenburg Thalmann 2021 Virtual Healthcare Conference on July 13, 2021, at 10:30 AM ET. A live and archived webcast will be accessible through the Company's Investor Relations page. SeaSpine is dedicated to developing surgical solutions for spinal disorders, offering a diverse range of orthobiologics and spinal implants. Its innovative products support spinal fusion in various procedures, catering to neurosurgeons and orthopedic spine surgeons. The company operates in the U.S. and approximately 30 other countries.

CARLSBAD, Calif., June 29, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the Company will present at the Ladenburg Thalmann 2021 Virtual Healthcare Conference on Tuesday, July 13, 2021, beginning at 10:30 AM ET.

A live and archived webcast of the event will be available from the Investor Relations page of the Company's website at investor.seaspine.com.

About SeaSpine
SeaSpine (www.seaspine.com) is a global medical technology company focused on the design, development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. SeaSpine has a comprehensive portfolio of orthobiologics and spinal implants solutions, as well as a market leading surgical navigation system, to meet the varying combinations of products that neurosurgeons and orthopedic spine surgeons need to perform fusion procedures on the lumbar, thoracic and cervical spine. SeaSpine's orthobiologics products consist of a broad range of advanced and traditional bone graft substitutes that are designed to improve bone fusion rates following a wide range of orthopedic surgeries, including spine, hip, and extremities procedures. SeaSpine's spinal implants portfolio consists of an extensive line of products to facilitate spinal fusion in degenerative, minimally invasive surgery (MIS), and complex spinal deformity procedures. Expertise in both orthobiologic sciences, as well as spinal implants, software, and advanced optics product development, allows SeaSpine to offer its surgeon customers a differentiated portfolio and a complete solution to meet their fusion requirements. SeaSpine currently markets its products in the United States and in approximately 30 countries worldwide through a committed network of increasingly exclusive distribution partners.

Investor Relations Contact
Leigh Salvo
(415) 937-5402
ir@seaspine.com

FAQ

What is the date and time of SeaSpine's presentation at the Ladenburg Thalmann Conference?

SeaSpine will present on July 13, 2021, at 10:30 AM ET.

Where can I watch the SeaSpine conference presentation?

The presentation will be available live and in archived form on the Investor Relations page of SeaSpine's website.

What is the focus of SeaSpine Holdings Corporation?

SeaSpine focuses on surgical solutions for the treatment of spinal disorders, including orthobiologics and spinal implants.

In how many countries does SeaSpine market its products?

SeaSpine markets its products in the United States and approximately 30 other countries.

What products does SeaSpine offer for spinal surgeries?

SeaSpine offers a comprehensive portfolio of orthobiologics, spinal implants, and a surgical navigation system for spinal fusion procedures.